{
    "2020-08-13": [
        [
            {
                "time": "2023-10-18",
                "original_text": "Eli Lilly, Novartis Have Most Valuable Pipeline Drugs",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Novartis",
                        "Valuable Pipeline Drugs"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-18",
                "original_text": "The Daily Biotech Pulse: Mesoblast Awaits Adcom Test, BioCryst Rallies On Insider Buying, Sorrento Hits Back At Short Seller",
                "features": {
                    "keywords": [
                        "Mesoblast",
                        "Adcom Test",
                        "BioCryst",
                        "Insider Buying",
                        "Sorrento",
                        "Short Seller"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}